Phase III randomized trial of high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) support as consolidation in patients (pts) with advanced ovarian cancer (AOC): 5-year follow-up of a GINECO/FNCLCC/SFGM‐TC study. - Cure,H.; Battista,C.; Guastalla,J.P.; Fabbro,M.; Tubiana,N.; Bourgeois,H.; Lioure,B.; Chiurazzi,B.; Paraiso,D.; Pujade-Lauraine,E. (J Clin Oncol, 2004)